Drug Shortage Report for TARO-ZOPICLONE
Report ID | 125962 |
Drug Identification Number | 02267926 |
Brand name | TARO-ZOPICLONE |
Common or Proper name | ZOPICLONE |
Company Name | SUN PHARMA CANADA INC |
Market Status | DORMANT |
Active Ingredient(s) | ZOPICLONE |
Strength(s) | 7.5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | N05CF |
ATC description | HYPNOTICS AND SEDATIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-09-01 |
Estimated end date | 2020-12-31 |
Actual end date | 2020-11-30 |
Shortage status | Resolved |
Updated date | 2020-12-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2020-12-03 | French | Compare |
v3 | 2020-12-03 | English | Compare |
v2 | 2020-10-08 | French | Compare |
v1 | 2020-10-08 | English | Compare |
Showing 1 to 4 of 4